Hong Qin

Years Active: 2020-2022
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

Zhenyuan Dong, Joo Y Song, Elana Thieme, Aaron J Anderson, Elizabeth Oh, Wesley A Cheng, Benjamin Z Kuang, Vincent Lee, Tiantian Zhang, Zhe Wang, Szymon Jakub Szymura, D Lynne Smith, Jianbing Zhang, Weihong Nian, Xintong Zheng, Feng He, Qing Zhou, Cha Soung-Chul, Alexey V Danilov, Hong Qin, Larry W Kwak
Generation of a humanized afucosylated BAFF-R antibody with broad activity against human B-cell malignancies. Blood advances (2022)
Hong Qin, Zhenyuan Dong, Xiuli Wang, Wesley A Cheng, Feng Wen, Weili Xue, Han Sun, Miriam Walter, Guowei Wei, D Lynne Smith, Xiuhua Sun, Fan Fei, Jianming Xie, Theano I Panagopoulou, Chun-Wei David Chen, Joo Y Song, Ibrahim Aldoss, Clarisse Kayembe, Luisa Sarno, Markus Müschen, Giorgio G Inghirami, Stephen J Forman, Larry W Kwak
CAR T cells targeting BAFF-R can overcome CD19 antigen loss in B cell malignancies. Science translational medicine 11 (511) (2020)
Zhenyuan Dong, Wesley A Cheng, D Lynne Smith, Brian Huang, Tiantian Zhang, Wen-Chung Chang, Xiuli Wang, Stephen J Forman, Larry W Kwak, Hong Qin
Antitumor efficacy of BAFF-R targeting CAR T cells manufactured under clinic-ready conditions. Cancer immunology, immunotherapy : CII 69 (10) (2020)

Hong Qin.css-eqlu8i{font-size:small;padding-left:4px;}